Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Skin Sensitisation (OECD 406, GPMT, guinea pig): not sensitising

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
Dec 26, 1996 - May 8, 1997
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Qualifier:
equivalent or similar to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Study conducted before LLNA was established.
Species:
guinea pig
Strain:
other: albino Crl:(HA)BR
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Charles River Laboratories, Inc.; Portage, Michigan, USA)
- Age at study initiation: young adult (age not precisely specified)
- Weight at study initiation: 350g - 550g
- Housing: individually in suspended screen-bottom stainless steel cages (during acclimation and throughout the study)
- Diet: Certified Guinea Pig Diet #5026 (PMI Feeds, Inc.) ad libitum
- Water: ad libitum
- Acclimation period: 7 days after receipt

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25
- Humidity (%): relative humidity 50% (+/-20%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
Route:
intradermal and epicutaneous
Vehicle:
unchanged (no vehicle)
Concentration / amount:
undiluted (since the test item was non-irritating based on the results of the range finding test).
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
undiluted (since the test item was non-irritating based on the results of the range finding test).
Adequacy of challenge:
highest non-irritant concentration
No. of animals per dose:
total 34 of any sex
- Irritation screen study: 4
- Main study: 20 (test group)
10 (Irritation control group)
Identification by individual numbered ear tag
Details on study design:
RANGE FINDING TESTS: Irritation screening study
- Four animals were treated with test item: undiluted, 25%, 50%, 75% (w/v in mineral oil). Each animal received two different concentrations.
- The test item was was applied to saturation to filter papers (Whatman No. 3, 2 cm x 2 cm), which were applied to both sides of each animal
(right and left side of the shaved back) and covered with overlapping strips of Blenderm™ tape and overwrapped with Elastoplast® tape.
- After 24 hours the patches were removed, and the application sites were wiped with wet disposable paper towels.
- The application sites were opserved at 24 and 48 hours after removal for dermal reactions.

MAIN STUDY

A. INDUCTION EXPOSURE
Intradermal injections (Day 1):
2 pairs of intradermal injections within a 2 cm x 4 cm-area (3 injections on each side of the midline of the shoulder region)
- Test group: anterior sites: 0.1 mL of Freund's Complete Adjuvant (FCA; 1:1 dilution with sterile water)
medial sites: 0.1 mL suspension of test material (5% w/v in mineral oil)
posterior sites: 0.1 mL suspension of test material in Freund's Complete Adjuvant (5% w/v in 1:1 FCA in sterile water)
- Control group: anterior sites: 0.1 mL of Freund's Complete Adjuvant (1:1 dilution with sterile water)
medial sites: 0.1 mL of mineral oil
posterior sites: 0.1 mL mineral oil in Freund's Complete Adjuvant
Topical application
- Pretreatment with 10% w/w sodium lauryl sulfate (SLS) (Day 7)
- The test item or control item was was applied to saturation to filter papers (Whatman No. 3, 2 cm x 2 cm), which were placed over the injection site
and covered with overlapping strips of Blenderm™ tape and overwrapped with Elastoplast® tape (Day 8).
- After48 hours the patches were removed and the application sites were wiped with wet disposable paper towels.
- Test groups: Test item, FCA
- Control group: vehicle control (mineral oil), FCA
- Site: shoulder
- Frequency of applications: 2 (intradermal injection and topical application)
- Duration: 48 h (topical application)
- Concentrations: undiluted test item

B. CHALLENGE EXPOSURE (Day 22; two weeks after topical application)
- No. of exposures: 1
- Day of challenge: test day 22
- Exposure period: 24 h
- Test groups: Test item, vehicle
- Control group: Test item, vehicle
- Site: flanks
- Concentrations: undiluted test item(right side) and vehicle (left side)
- Application sites were covered with overlapping strips of Blenderm™ tape and overwrapped with Elastoplast® tape.
- Evaluation (hr after challenge): 24 h and 48 h

Clinical observation: daily until experimental termination
Challenge controls:
A positive control study using the same maximisation method was conducted within six month of the conduct of the main study.
Control group: 5 animals
Test group: 10 animals
Positive control substance(s):
yes
Remarks:
2,4-dinitrochlorobenzene (0.1% w/v in acetone)
Positive control results:
1st reading (24 hrs after challenge): All animals of the test group challenged with 4-dinitrochlorobenzene (0.1% w/v in acetone) exhibited dermal
reactions in the range between 2 and 3 at the treated areas;
2nd reading (48 hrs after challenge): All animals of the test group challenged with 4-dinitrochlorobenzene (0.1% w/v in acetone) exhibited
desquamation, one in combination with subcutaneous hemorrhaging.
Control application of the test group did not result in any reactions.
All animals in the vehicle control group kept healthy after challenging.
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
undiluted test item
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
no clinical signs observed
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
mineral oil
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no clinical signs observed
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
undiluted test item
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
no clinical signs observed
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
mineral oil
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no clinical signs observed
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
induction: 0.1% (w/v) intradermal, 0.3 % (w/v) epictuaneous, challenge: 0.1% (w/v)
No. with + reactions:
9
Total no. in group:
9
Remarks on result:
positive indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
induction: 0.1% (w/v) intradermal, 0.3 % (w/v) epictuaneous, challenge: 0.1% (w/v)
No. with + reactions:
9
Total no. in group:
9
Remarks on result:
positive indication of skin sensitisation

In the preliminary irritation screening study the test material caused no dermal reaction in any animal at any concentration. Therefore it was administered undiluted for topical induction and for the challenge phase in the main study.

Interpretation of results:
other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
Conclusions:
Under the conditions of the conducted GPMT test, the test substance did not exhibit sensitising properties.
CLP: not classified
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

A valid GLP-conform Guinea Pig Maximisation Test (Corning Hazelton 1997), provided no evidence of a sensitisation potential of Alkylation and transalkylation products of biphenyl with propene.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

The available skin sensitisation study performed with Alkylation and transalkylation products of biphenyl with propen is conclusive but not sufficient for classification, and thus, does not meet the criteria for classification according to Regulation (EC) No. 1272/2008 (CLP).